MedTrace Logo

RSV-MVA-BN Vaccine Phase I Trial, Intranasal Application in Adults.

NCT02864628 · Status: WITHDRAWN · Phase: PHASE1 · Type: INTERVENTIONAL

Last updated 2018-08-27

No results posted yet for this study

Summary

A total of 96 subjects will be recruited into 5 groups. Each subject will receive either two vaccinations with MVA-BN-RSV vaccine or placebo.

Conditions

  • Respiratory Syncytial Virus Infections

Interventions

BIOLOGICAL

MVA-BN-RSV

MVA-mBN294B

OTHER

Placebo

Tris Buffered Saline

Sponsors & Collaborators

  • Bavarian Nordic

    lead INDUSTRY

Principal Investigators

  • Carlos Fierro, MD · Johnson County Clin-Trials (JCCT)

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
55 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-09-30
Primary Completion
2017-10-27
Completion
2017-10-27
FDA Drug
Yes

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02864628 on ClinicalTrials.gov